melanotan 1 how to use MC1R-Selective Peptide for Melanocortin Research Melanotan 1 Canada | Maple

Afamelanotide is FDA-approved for EPP at 16 mg subcutaneous implant every 60 days roughly 2 mg/day of continuous release (Langendonk et al., 2015)

PT-141, also known as Bremelanotide in scientific literature, has been discussed in research involving melanocortin receptor biology, peptide signaling, molecular pharmacology, receptor interaction models, and controlled laboratory studies

Risk factors Dose and treatment duration The higher the dose and the longer the treatment duration, the higher the incidence of adverse reactions

The jar might lack a label, but you can trust that its just as pure & top-notch as our full brand items